1-{4-[3-(6-Methylpyridin-2-yl)prop-2-yn-1-ylidene]piperidin-1-yl}-2-phenylethanone

ID: ALA4525950

PubChem CID: 87551058

Max Phase: Preclinical

Molecular Formula: C22H22N2O

Molecular Weight: 330.43

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc(C#CC=C2CCN(C(=O)Cc3ccccc3)CC2)n1

Standard InChI:  InChI=1S/C22H22N2O/c1-18-7-5-11-21(23-18)12-6-10-19-13-15-24(16-14-19)22(25)17-20-8-3-2-4-9-20/h2-5,7-11H,13-17H2,1H3

Standard InChI Key:  RLOLKWLPQCITPX-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
   28.2495  -19.1627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2483  -19.9822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9564  -20.3912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6660  -19.9817    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.6632  -19.1591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9546  -18.7538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9562  -21.2084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3694  -18.7478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0739  -18.3331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7782  -17.9186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4893  -18.3213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4899  -19.1389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1970  -19.5415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9037  -19.1304    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.8988  -18.3123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1872  -17.9052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6132  -19.5358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6170  -20.3529    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.3191  -19.1239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0287  -19.5293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0276  -20.3442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7363  -20.7495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4431  -20.3376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4367  -19.5162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7274  -19.1146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  3  7  1  0
  5  8  1  0
  8  9  3  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 14 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
M  END

Associated Targets(Human)

GRM5 Tchem Metabotropic glutamate receptor 5 (5733 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Grm1 Metabotropic glutamate receptor 1 (1186 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 330.43Molecular Weight (Monoisotopic): 330.1732AlogP: 3.53#Rotatable Bonds: 2
Polar Surface Area: 33.20Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.19CX LogP: 3.33CX LogD: 3.33
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.79Np Likeness Score: -0.78

References

1. Graziani D, Caligari S, Callegari E, De Toma C, Longhi M, Frigerio F, Dilernia R, Menegon S, Pinzi L, Pirona L, Tazzari V, Valsecchi AE, Vistoli G, Rastelli G, Riva C..  (2019)  Evaluation of Amides, Carbamates, Sulfonamides, and Ureas of 4-Prop-2-ynylidenecycloalkylamine as Potent, Selective, and Bioavailable Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5.,  62  (3): [PMID:30624919] [10.1021/acs.jmedchem.8b01226]

Source